Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
21,284,113
-
Shares change
-
+1,222,798
-
Total reported value, excl. options
-
$919,504,408
-
Value change
-
+$53,403,136
-
Number of buys
-
73
-
Number of sells
-
-32
-
Price
-
$43.2
Significant Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q2 2020
112 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2020.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,284,113 shares
of 45,101,565 outstanding shares and own 47.19% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2,327,926 shares), BlackRock Inc. (2,311,792 shares), Sofinnova Investments, Inc. (2,194,278 shares), Cormorant Asset Management, LP (1,574,683 shares), FMR LLC (1,310,742 shares), VANGUARD GROUP INC (1,239,664 shares), STATE STREET CORP (955,589 shares), ALLIANCEBERNSTEIN L.P. (887,397 shares), LOOMIS SAYLES & CO L P (773,987 shares), and Artisan Partners Limited Partnership (626,266 shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.